SSA
GILD icon

Sierra Summit Advisors’s Gilead Sciences GILD Stock Holding History

Sierra Summit Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
10,532
-6,977
-40% -$919K 0.15% 92
2026
Q1 		$2.44M Sell
17,509
-6,644
-28% -$930K 0.35% 54
2025
Q4 		$2.96M Buy
24,153
+554
+2% +$67.3K 0.45% 42
2025
Q3 		$2.62M Sell
23,599
-215
-0.9% -$24.4K 0.4% 45
2025
Q2 		$2.64M Sell
23,814
-318
-1% -$33.8K 0.47% 40
2025
Q1 		$2.7M Buy
24,132
+1,057
+5% +$109K 0.59% 38
2024
Q4 		$2.13M Buy
23,075
+9,305
+68% +$838K 0.43% 41
2024
Q3 		$1.15M Buy
13,770
+2,362
+21% +$180K 0.27% 52
2024
Q2 		$783K Buy
+11,408
New +$761K 0.19% 63
2024
Q1 		– Sell
-2,900
Closed -$235K – 178
2023
Q4 		$235K Buy
+2,900
New +$226K 0.07% 170

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sierra Summit Advisors's GILD Position: Q2 2026 in Review

Sierra Summit Advisors reduced its Gilead Sciences (GILD) stake by 40% in Q2 2026, selling an estimated $919K and leaving 10,532 shares worth $1.33M. The position accounts for 0.15% of the portfolio, ranked #92.

Sierra Summit Advisors first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.96M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sierra Summit Advisors held 10,532 shares of Gilead Sciences worth $1.33M as of Q2 2026.
  • Sierra Summit Advisors sold 6,977 Gilead Sciences shares in Q2 2026, an estimated $919K.
  • Gilead Sciences made up 0.15% of Sierra Summit Advisors's portfolio in Q2 2026, its #92 holding.
  • Sierra Summit Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Sierra Summit Advisors's Gilead Sciences position peaked at $2.96M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.